Label Changes for:
Allegra-D 24 hour (fexofenadine HCL 180mg/pseudoephedrinie HCL 240mg) extended release tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2010
- ischemic colitis have been reported